MEDIZINISCHE VORRICHTUNG

European patent · EP3337653 · In force

Register entry

Publication number
EP3337653
Application number
EP16753432
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 11, 2016
Published
Jun 27, 2018
Granted
Oct 9, 2019
Protection ends at the latest
Aug 10, 2036
Next annual fee due
Aug 31, 2027
IPC classes
B29C 70/34 (2006.01)
A61L 27/44 (2006.01)
B29C 70/70 (2006.01)
B29L 31/00 (2006.01)
A61B 17/86 (2006.01)
A61B 17/00 (2006.01)
Priority
GB 201514579 17.08.2015
PCT application
PCT/GB2016/052500 11.08.2016
PCT publication
WO2017/029476 23.02.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  4. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  5. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  6. Oct 9, 2019

    Granted

    Published in Swissreg on 09.10.2019

Parties

Holder

Invibio Device Component Manufacturing Limited

Victrex Technology Centre Hillhouse International, Thornton Cleveleys, Lancashire FY5 4QD, GB

Inventor

LAMORINIERE, Steven

Thornton Cleveleys Lancashire FY5 4QD, GB

BURGESS, Michael

Thornton Cleveleys Lancashire FY5 4QD, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.